验证数据展示
Planning an IHC experiment? We recommend our IHCeasy CD90 Ready-To-Use IHC Kit. CD90 primary antibody included.
发表文章中的应用
IHC | See 1 publications below |
IF | See 3 publications below |
产品信息
17641-1-AP targets CD90 in IHC, IF, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
经测试应用 | IP, IHC, ELISA Application Description |
文献引用应用 | IHC, IF |
经测试反应性 | human, mouse, rat |
文献引用反应性 | human, rat |
免疫原 | CD90 fusion protein Ag11792 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | Thy-1 cell surface antigen |
别名 | CD90, CDw90, Thy 1 antigen, Thy 1 cell surface antigen, Thy 1 membrane glycoprotein, THY1 |
计算分子量 | 161 aa, 18 kDa |
GenBank蛋白编号 | BC065559 |
基因名称 | CD90/Thy1 |
Gene ID (NCBI) | 7070 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P04216 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
CD90, also known as THY1, is a 25-35 kD protein that is expressed on 1-4% of human fetal liver cells, cord blood cells, and bone marrow cells. CD90 is one of the essential surface molecules expressed on human MSC from bone marrow and other sources. Activation of Thy-1 has been reported to promote T cell activation. It also affects numerous nonimmunologic biological processes, including cellular adhesion, neurite outgrowth, tumor growth, migration, and cell death.
发表文章
Species | Application | Title |
---|---|---|
ACS Appl Mater Interfaces Sandwich Biomimetic Scaffold Based Tendon Stem/Progenitor Cell Alignment in a 3D Microenvironment for Functional Tendon Regeneration | ||
iScience PIK3CA mutations enhance the adipogenesis of ADSCs in facial infiltrating lipomatosis through TRPV1 | ||
Bioact Mater A novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: Application to endogenous regeneration of articular cartilage | ||
J Transl Med Posterior iliac crest vs. proximal tibia: distinct sources of anti-inflammatory and regenerative cells with comparable 6-month clinical outcomes in treatment of osteoarthritis |